Elevated pretreatment neutrophil-to-lymphocyte ratio indicate low survival rate in apatinib-treated patients with non-small cell lung cancer: A STROBE-compliant article

This study aimed to analyze the predictive value of the neutrophil-to-lymphocyte ratio (NLR) to better clarify which patients with advanced non-small cell lung cancer (NSCLC) would benefit most from apatinib after multiline treatment for drug resistance. This observational cohort study involved pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Ya-Nan, Chen, Hai-Ming, Liu, Xin-Fu, Gu, Wei-Guang, Lu, Yi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704969/
https://www.ncbi.nlm.nih.gov/pubmed/36451494
http://dx.doi.org/10.1097/MD.0000000000032043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704969/
https://www.ncbi.nlm.nih.gov/pubmed/36451494
http://dx.doi.org/10.1097/MD.0000000000032043

Ejemplares similares